SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 1, 1995
(Exact name of registrant as specified in its charter)
Delaware 1-4219 C-74-1339132
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation) File Number) Identification No.)
P. O. Box 4240
Houston, Texas 77210-4240
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (713) 940-6100
ITEM 5. OTHER EVENTS.
On March 1, 1995, Zapata Corporation, a Delaware corporation (the
"Company") entered into an agreement to sell Zapata Protein, Inc., a wholly
owned subsidiary of the Company ("ZPI"), to a group led by ZPI's management.
ZPI comprises the Company's marine protein division. The sale transaction
involves a purchase price of approximately $56 million in cash. In addition,
ZPI's indebtedness of approximately $11 million will no longer be included in
the consolidated financial statements of the Company. The Company's Annual
Report on Form 10-K for the year ended September 30, 1994 and quarterly report
on Form 10-Q for the three months ended December 31, 1994 reported ZPI as a
On March 2, 1995, Avram A. Glazer, a director of the Company,
was named President and Chief Executive Officer of the Company, replacing
Malcolm I. Glazer, who will remain as Chairman of the Board of Directors. R. C.
Lassiter stepped down as acting Chief Operating Officer of the Company and
remains a member of the Company's Board of Directors.
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
By: /s/ Joseph L. von Rosenberg III
Joseph L. von Rosenberg III
Vice President, General Counsel
and Corporate Secretary
Date: March 15, 1995